Human papillomavirus (HPV) is a common sexually transmitted infection, with an estimated 1 to 5.5 million new infections per year in the United States. Over 200 HPV types have been identified, with 85 well-characterized and 120 partially characterized. HPV is categorized as cutaneous or mucosal, with high-risk types associated with cervical cancer and low-risk types causing benign warts. HPV is linked to various clinical conditions, ranging from benign warts to cancer. Most HPV infections are benign, but persistent infections with high-risk types can lead to cervical cancer. HPV is associated with cervical cancer, which is the third most common cancer in women in the United States. HPV is the most common cause of cervical cancer, with 99.7% of cases linked to high-risk HPV types. HPV is transmitted through skin-to-skin contact and is resistant to heat and desiccation. Factors such as multiple sexual partners, early sexual activity, and smoking increase the risk of HPV infection and cervical cancer. HPV infection is most common in sexually active young women, but cervical cancer is more common in women over 35. HPV DNA testing is used to detect high-risk HPV types, with results indicating the likelihood of cervical cancer. HPV DNA testing is used to guide treatment decisions for patients with abnormal Pap smear results. HPV is detected through various methods, including conventional cytology, monolayer cytology, histopathology, and HPV DNA detection. HPV DNA detection methods include type-specific PCR, general primer PCR, and liquid hybridization. HPV DNA testing is used to identify high-risk HPV types and guide treatment decisions. HPV is associated with various cancers, including cervical, anal, and oropharyngeal cancers. HPV infection can lead to cervical cancer through a complex process involving viral replication, oncogenic transformation, and immune evasion. HPV DNA testing is used to detect high-risk HPV types and guide treatment decisions. HPV is a common sexually transmitted infection, with over 200 types identified. HPV is associated with various clinical conditions, ranging from benign warts to cancer. Most HPV infections are benign, but persistent infections with high-risk types can lead to cervical cancer. HPV is transmitted through skin-to-skin contact and is resistant to heat and desiccation. Factors such as multiple sexual partners, early sexual activity, and smoking increase the risk of HPV infection and cervical cancer. HPV infection is most common in sexually active young women, but cervical cancer is more common in women over 35. HPV DNA testing is used to detect high-risk HPV types, with results indicating the likelihood of cervical cancer. HPV DNA testing is used to guide treatment decisions for patients with abnormal Pap smear results. HPV is detected through various methods, including conventional cytology, monolayer cytology, histopathology, and HPV DNA detection. HPV DNA detection methods include type-specific PCR, general primer PCR, and liquid hybridization.Human papillomavirus (HPV) is a common sexually transmitted infection, with an estimated 1 to 5.5 million new infections per year in the United States. Over 200 HPV types have been identified, with 85 well-characterized and 120 partially characterized. HPV is categorized as cutaneous or mucosal, with high-risk types associated with cervical cancer and low-risk types causing benign warts. HPV is linked to various clinical conditions, ranging from benign warts to cancer. Most HPV infections are benign, but persistent infections with high-risk types can lead to cervical cancer. HPV is associated with cervical cancer, which is the third most common cancer in women in the United States. HPV is the most common cause of cervical cancer, with 99.7% of cases linked to high-risk HPV types. HPV is transmitted through skin-to-skin contact and is resistant to heat and desiccation. Factors such as multiple sexual partners, early sexual activity, and smoking increase the risk of HPV infection and cervical cancer. HPV infection is most common in sexually active young women, but cervical cancer is more common in women over 35. HPV DNA testing is used to detect high-risk HPV types, with results indicating the likelihood of cervical cancer. HPV DNA testing is used to guide treatment decisions for patients with abnormal Pap smear results. HPV is detected through various methods, including conventional cytology, monolayer cytology, histopathology, and HPV DNA detection. HPV DNA detection methods include type-specific PCR, general primer PCR, and liquid hybridization. HPV DNA testing is used to identify high-risk HPV types and guide treatment decisions. HPV is associated with various cancers, including cervical, anal, and oropharyngeal cancers. HPV infection can lead to cervical cancer through a complex process involving viral replication, oncogenic transformation, and immune evasion. HPV DNA testing is used to detect high-risk HPV types and guide treatment decisions. HPV is a common sexually transmitted infection, with over 200 types identified. HPV is associated with various clinical conditions, ranging from benign warts to cancer. Most HPV infections are benign, but persistent infections with high-risk types can lead to cervical cancer. HPV is transmitted through skin-to-skin contact and is resistant to heat and desiccation. Factors such as multiple sexual partners, early sexual activity, and smoking increase the risk of HPV infection and cervical cancer. HPV infection is most common in sexually active young women, but cervical cancer is more common in women over 35. HPV DNA testing is used to detect high-risk HPV types, with results indicating the likelihood of cervical cancer. HPV DNA testing is used to guide treatment decisions for patients with abnormal Pap smear results. HPV is detected through various methods, including conventional cytology, monolayer cytology, histopathology, and HPV DNA detection. HPV DNA detection methods include type-specific PCR, general primer PCR, and liquid hybridization.